Lees K R, Curzio J, Farish E, Borland W W, Rubin P C
University Department of Materia Medica, Stobhill General Hospital, Glasgow, UK.
Eur J Clin Pharmacol. 1987;33(4):415-7. doi: 10.1007/BF00637640.
Epanolol is a beta-adrenoceptor antagonist with partial agonist activity, a property which could be useful in reducing the fatigue associated with beta blockers. In a double-blind, randomized, crossover study we have investigated the effects of metoprolol 100 mg b.d., epanolol 100 mg b.d., and epanolol 200 mg b.d. on blood pressure, heart rate, and exercise-induced fatigue in 10 hypertensive men. Fatigue was measured subjectively by the Borg rating scale and objectively by blood lactate concentrations. Resting and exercise heart rates were lower with metoprolol than with either dose of epanolol. Preexercise standing diastolic blood pressure was lowered by metoprolol, but there were no other treatment effects on blood pressure. Exercise-induced fatigue was not altered by any treatment, whether measured subjectively or objectively. These results do not support the hypothesis that partial agonist activity improves exercise tolerance in hypertensive patients treated with beta-adrenoceptor antagonists.
依泮洛尔是一种具有部分激动剂活性的β-肾上腺素能受体拮抗剂,这一特性可能有助于减轻与β受体阻滞剂相关的疲劳。在一项双盲、随机、交叉研究中,我们调查了每日两次服用100毫克美托洛尔、每日两次服用100毫克依泮洛尔以及每日两次服用200毫克依泮洛尔对10名高血压男性的血压、心率和运动诱发疲劳的影响。疲劳通过Borg评分量表进行主观测量,并通过血乳酸浓度进行客观测量。美托洛尔组的静息心率和运动心率低于任何一种剂量依泮洛尔组。美托洛尔可降低运动前站立位舒张压,但其他治疗对血压无影响。无论主观还是客观测量,任何治疗均未改变运动诱发的疲劳。这些结果不支持以下假设:即部分激动剂活性可改善接受β-肾上腺素能受体拮抗剂治疗的高血压患者的运动耐量。